acetyl-l-carnitine diabetic neuropathy rct doi Pharmacological and Nonpharmacological Treatments for Painful Peripheral Diabetic neuropathy: cutting-edge research and

10.1038/nature24297 77 HaoS.YuJ.HeW.HuangQ.ZhaoY.LiangB.et al (2017)

doi: 10.1124/jpet.103.049940 37 PrasnickaA.CermanovaJ.HrochM.DolezelovaE.RozkydalovaL.SmutnyT.et al

Ciertos medicamentos pueden interactuar con la levocarnitina

F.LiuH.ZengT

Substitution of cysteine for a conserved alanine residue in the catalytic center of type II iodothyronine deiodinase alters interaction with reducing cofactor

DBH exists in both a membrane-bound and soluble form (Sabban et al., 1983) and studies utilizing rat PC12 cells and human SH-SY5Y cells have demonstrated that once packaged into secretory granules, DBH-containing vesicles are released not only in response to stimulation but are also constitutively released into the extracellular space under resting conditions (McHugh et al., 1985